Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Marte C. Liefaard"'
Autor:
Donna O. Debets, Erik L. de Graaf, Marte C. Liefaard, Gabe S. Sonke, Esther H. Lips, Anna Ressa, Maarten Altelaar
Publikováno v:
iScience, Vol 27, Iss 6, Pp 109858- (2024)
Summary: In this study, we measured the kinase activity profiles of 32 pre-treatment tumor biopsies of HER2-positive breast cancer patients. The aim of this study was to assess the prognostic potential of kinase activity levels, to identify potential
Externí odkaz:
https://doaj.org/article/bfdbc26b61c74528a8ee376a35d970f6
Autor:
Anna van der Voort, Marte C. Liefaard, Mette S. van Ramshorst, Erik van Werkhoven, Joyce Sanders, Jelle Wesseling, Astrid Scholten, Marie Jeanne T.F.D. Vrancken Peeters, Linda de Munck, Sabine Siesling, Gabe S. Sonke
Publikováno v:
Breast, Vol 65, Iss , Pp 110-115 (2022)
Background: Pathologic complete response (pCR) rates in early stage HER2-positive breast cancer improved after pertuzumab was added to neoadjuvant treatment. However, survival benefit is less-well established and seems mostly limited to node-positive
Externí odkaz:
https://doaj.org/article/8afd7b7a51b54354ada4317477a5ee96
Autor:
Marte C. Liefaard, Kat S. Moore, Lennart Mulder, Daan van den Broek, Jelle Wesseling, Gabe S. Sonke, Lodewyk F. A. Wessels, Matti Rookus, Esther H. Lips
Publikováno v:
BJC: British Journal of Cancer, 128(8)
Background Studies have shown that blood platelets contain tumour-specific mRNA profiles tumour-educated platelets (TEPs). Here, we aim to train a TEP-based breast cancer detection classifier. Methods Platelet mRNA was sequenced from 266 women with s
Autor:
Donna O. Debets, Erik L. de Graaf, Marte C. Liefaard, Gabe S. Sonke, Esther H. Lips, Anna Ressa, Maarten Altelaar
In this study, we measured the kinase activity profiles of 32 pre-treatment tumour biopsies of HER2-positive breast cancer patients. The aim of this study was to assess the prognostic potential of kinase activity levels to identify potential mechanis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5cb2afc7fcb3d14029024c667c1b9dc5
https://doi.org/10.1101/2022.09.23.508980
https://doi.org/10.1101/2022.09.23.508980
Autor:
Bin Lou, Jelle Wesseling, Tommaso Mansi, Marte C. Liefaard, Nola M. Hylton, Esther H. Lips, Lajos Pusztai
Publikováno v:
American Society of Clinical Oncology Educational Book. :12-23
Advances in tissue analysis methods, image analysis, high-throughput molecular profiling, and computational tools increasingly allow us to capture and quantify patient-to-patient variations that impact cancer risk, prognosis, and treatment response.
Autor:
Marte C Liefaard, Anna van der Voort, Joyce Sanders, Shiva Vonk, Hugo M Horlings, Sabine Siesling, Linda de Munck, Elise van Leeuwen-Stok, Miranda Kleijn, Lorenza Mittempergher, Midas M Kuilman, Esther H Lips, Gabe S Sonke
Publikováno v:
Cancer Research. 82:PD15-07
Background: The addition of pertuzumab to neoadjuvant trastuzumab-containing chemotherapy significantly improves pathological complete response (pCR) rates in patients with HER2-positive breast cancer. However, effects on long-term survival outcomes
Autor:
Marte C. Liefaard, Mette S. van Ramshorst, Marie-Jeanne T. F. D. Vrancken Peeters, Anna van der Voort, Linda de Munck, Jelle Wesseling, Erik van Werkhoven, Gabe S. Sonke, A.N. Scholten
Publikováno v:
Cancer Research. 81:PS10-07
Background Pertuzumab greatly improves pathologic complete response (pCR) rates in early stage HER2-positive breast cancer. Long-term benefit of pertuzumab, however, is less well established, as follow-up of the NEOSPHERE and APHINITY trials did not
Autor:
Bakhos A. Tannous, Thomas Wurdinger, Nik Sol, Myron G. Best, S. In ’T Veld, Esther H. Lips, Marte C. Liefaard, Gabe S. Sonke, Jelle Wesseling, Matti A. Rookus
Publikováno v:
Annals of Oncology. 30:iii13
Autor:
Marte C. Liefaard, Anna Vitezova, Jessica C. Kiefte-de Jong, Abbas Dehghan, Symen Ligthart, Albert Hofman, Oscar H. Franco, M. Carola Zillikens, André G. Uitterlinden
Publikováno v:
PLoS One (print), 10(7). Public Library of Science
PLoS ONE, Vol 10, Iss 7, p e0131740 (2015)
PLoS ONE
PLoS ONE, Vol 10, Iss 7, p e0131740 (2015)
PLoS ONE
Vitamin D deficiency is widely prevalent and has been associated with many diseases. It has been suggested that vitamin D has effects on the immune system and inhibits inflammation. The aim of our study was to investigate whether vitamin D has an inh